Irigenin inhibits glioblastoma progression through suppressing YAP/β-catenin signaling

Glioblastoma (GBM) is the most malignant glioma in brain tumors with low survival and high recurrence rate. Irigenin, as an isoflavone compound extracted from Shegan, has shown many pharmacological functions such as antioxidant, anti-inflammatory and anti-tumor. However, the effects of irigenin on G...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Jiayun, Sun, Shanshan, Zhang, Wei, Dong, Jianhong, Huang, Changgang, Wang, Xin, Jia, Mengxian, Yang, Hao, Wang, Yongjie, Jiang, Yuanyuan, Cao, Liying, Huang, Zhihui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748621/
https://www.ncbi.nlm.nih.gov/pubmed/36532767
http://dx.doi.org/10.3389/fphar.2022.1027577

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9748621/
https://www.ncbi.nlm.nih.gov/pubmed/36532767
http://dx.doi.org/10.3389/fphar.2022.1027577

Ejemplares similares